PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,066,783 | +242.1% | 47,603 | +520.8% | 0.04% | +225.0% |
| Q2 2023 | $311,858 | -17.2% | 7,668 | -22.3% | 0.01% | -47.8% |
| Q4 2022 | $376,509 | -20.2% | 9,864 | +4.9% | 0.02% | -20.7% |
| Q3 2022 | $472,000 | +74.2% | 9,406 | +39.0% | 0.03% | +190.0% |
| Q2 2022 | $271,000 | +3.8% | 6,768 | -3.4% | 0.01% | 0.0% |
| Q1 2022 | $261,000 | -74.1% | 7,004 | -74.2% | 0.01% | -82.8% |
| Q3 2021 | $1,009,000 | +276.5% | 27,116 | +379.1% | 0.06% | +346.2% |
| Q1 2021 | $268,000 | -56.1% | 5,660 | -43.4% | 0.01% | -50.0% |
| Q4 2020 | $610,000 | +28.7% | 9,998 | -1.5% | 0.03% | +18.2% |
| Q3 2020 | $474,000 | -36.9% | 10,149 | -39.7% | 0.02% | -59.3% |
| Q1 2020 | $751,000 | +112.1% | 16,824 | +128.6% | 0.05% | +237.5% |
| Q4 2019 | $354,000 | -56.7% | 7,361 | -69.5% | 0.02% | -61.0% |
| Q3 2019 | $817,000 | – | 24,172 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |